Company Filing History:
1 out of 2,968 
1 out of 702 
Years Active: 2009
Title: Debrabata RayChaudhuri: Innovator in Microbial Cell Division Inhibition
Introduction
Debrabata RayChaudhuri is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of microbial cell division through his innovative research and patent work. His expertise lies in developing methods and compounds that inhibit cell division, which has important implications for treating microbial infections.
Latest Patents
Debrabata RayChaudhuri holds a patent for "Compound combinations for inhibiting cell division and methods for their identification and use." This invention provides in vitro assays, such as FtsZ GTPase assays, and in vivo assays to identify specific compounds and combinations that affect microbial cell division. The patent details how certain compound combinations can inhibit cell survival or growth at concentrations below their individual minimum inhibitory concentrations (MICs). Notably, some combinations exhibit synergistic effects, including those that inhibit FtsZ GTPase activity alongside other mechanisms of growth inhibition. The invention also encompasses pharmaceutical compositions with anti-microbial activity and methods for treating microbial infections.
Career Highlights
Throughout his career, Debrabata RayChaudhuri has worked with prestigious institutions such as Harvard College and Tufts College. His research has focused on understanding the mechanisms of microbial cell division and developing innovative solutions to combat microbial infections.
Collaborations
Debrabata has collaborated with notable professionals in his field, including Marc W Kirschner. Their joint efforts have contributed to advancements in the understanding of microbial cell division and the development of effective treatments.
Conclusion
Debrabata RayChaudhuri is a prominent inventor whose work in inhibiting microbial cell division has the potential to significantly impact the field of medicine. His innovative approaches and patented inventions are paving the way for new treatments for microbial infections.